← Leaderboards
Jessica Conrad Brown
University Of Utah
$3,430,834
Attributed
$3,430,834
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $762.5K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,430,834 · 2
By mechanism
R01$3,430,834 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pathogen”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Thomas Denny · Duke University$42,477,454
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Sujatha Rashid · American Type Culture Collection$37,889,194
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
PathogenCellsGrowthMycosesPreventMeningitisCryptococcus NeoformansFungusInfectionMutantPathway InteractionsPharmaceutical PreparationsPathogenic FungusMolecularCessation Of LifeCryptococcusExperimental StudyFungal MeningitisImmunocompromised HostBlood CirculationBloodAids/Hiv ProblemBiogenesisCerebrospinal Fluid
Grant awards (9)
Immune modulation during infection by a secreted fungal polysaccharide$381,250
R01 · FY2022 · AI · contact PI
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.$381,250
R01 · FY2022 · AI · contact PI
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.$381,250
R01 · FY2021 · AI · contact PI
Immune modulation during infection by a secreted fungal polysaccharide$381,250
R01 · FY2021 · AI · contact PI
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.$381,250
R01 · FY2020 · AI · contact PI
Immune modulation during infection by a secreted fungal polysaccharide$381,250
R01 · FY2020 · AI · contact PI
Immune modulation during infection by a secreted fungal polysaccharide$381,250
R01 · FY2019 · AI · contact PI
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.$381,250
R01 · FY2019 · AI · contact PI
Immune modulation during infection by a secreted fungal polysaccharide$380,834
R01 · FY2018 · AI · contact PI